Internal Medicine, Pulmonary Disease · Schenectady, NY
NPI
1003979121
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
2125 River Road, Suite 203
Schenectady, NY, 12309
Phone (518) 831-8530
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,264 services
Medicare patients, 2024
325
Average age 73
Drug cost, 2024
$2.2M
5,548 prescriptions
Company payments, 2025
$2,011
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abul K Azad was code 99214 (office e&m - established), 428 times for 242 patients. In total Abul K Azad billed 1,264 services in 31 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 428 | 242 | $79.69 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 168 | 130 | $11.94 | $2,006 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 164 | 36 | $45.12 | $7,400 |
| 99204 Office E&M - New | Office | 79 | 79 | $109.55 | $8,655 |
| 94729 Pulmonary Function Testing | Office | 75 | 72 | $38.60 | $2,895 |
| 94726 Pulmonary Function Testing | Office | 71 | 68 | $38.41 | $2,727 |
| 94010 Pulmonary Function Testing | Office | 68 | 63 | $17.91 | $1,218 |
| 94060 Pulmonary Function Testing | Office | 39 | 39 | $27.34 | $1,066 |
| 99213 Office E&M - Established | Office | 34 | 31 | $55.10 | $1,874 |
| 99215 Office E&M - Established | Office | 30 | 28 | $125.19 | $3,756 |
| 94618 Pulmonary Function Testing | Office | 15 | 12 | $25.62 | $384 |
By year: 2022 $71K for 1,088 services; 2023 $70K for 1,049 services; 2024 $70K for 1,264 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abul K Azad prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 619 prescriptions and refills. In total Abul K Azad wrote 5,548 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 619 | 771 | 234 | $23K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 497 | 814 | 121 | $505K |
| Montelukast Sodium Generic | 265 | 678 | 85 | $3,330 |
| Breo Ellipta Fluticasone/Vilanterol | 250 | 336 | 73 | $129K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 218 | 378 | 62 | $170K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 206 | 319 | 57 | $33K |
| Omeprazole Generic | 201 | 358 | 51 | $2,159 |
| Prednisone Generic | 159 | 227 | 81 | $586 |
| Famotidine Generic | 151 | 352 | 45 | $1,777 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 149 | 197 | 34 | $121K |
| Gabapentin Generic | 126 | 195 | 30 | $1,887 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 110 | 167 | 35 | $25K |
| Fluticasone Propionate Generic | 95 | 170 | 36 | $1,186 |
| Atorvastatin Calcium Generic | 92 | 258 | 30 | $578 |
| Jardiance Empagliflozin | 84 | 108 | 17 | $59K |
Brand drugs: 2,485 claims; generic drugs: 3,030 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abul K Azad $2,011 ($2,011 in general payments such as food, travel and fees) from 16 companies. The largest payer was GlaxoSmithKline, LLC. with $614.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 35 | $614 |
| AstraZeneca Pharmaceuticals LP AZN | 25 | $612 |
| Amgen Inc. AMGN | 7 | $155 |
| Verona Pharma, Inc. VRNA | 6 | $138 |
| Grifols USA, LLC | 4 | $93.21 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $61.23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.33 |
| Insmed, Inc. INSM | 2 | $46.88 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $43.34 |
| Pfizer Inc. PFE | 2 | $40.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.